BridgeBio Pharma (BBIO) Ownership - Who Owns BridgeBio Pharma?

1,472 Followers

Recent Insider Trading Activity

Date	Name	Activity	Value
Nov 19, 2025	Andrew Lo	xxxxxxxxxxxxx	$6319093
Nov 14, 2025	Hannah Valantine	xxxxxxxxxxxxx	$1683728
Nov 07, 2025	Ronald J Daniels	xxxxxxxxxxxxx	$3888895
Sep 08, 2025	Frank Mccormick	xxxxxxxxxxxxx	$3933100

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Bridgewater Associates, Lp	xxxxxxxxxxxxx	$3302226
Dec 31, 2023	Viking Global Investors Lp	xxxxxxxxxxxxx	$1100992012
Dec 31, 2023	Primecap Management Co	xxxxxxxxxxxxx	$43574823
Dec 31, 2023	Fisher Asset Management Llc	xxxxxxxxxxxxx	$17776352

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value

FAQ

Who Owns BridgeBio Pharma Inc (BBIO)?

Currently, no data Available

What percentage of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors?

Currently, no data Available

What percentage of BridgeBio Pharma Inc (BBIO) stock is held by retail investors?

Currently, no data Available

Who owns the most shares of BridgeBio Pharma Inc (BBIO)?

Currently, no data Available

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.